Kangmei Pharmaceutical Co., Ltd. (600518.SS) SHH

1.98

-0.01(-0.50%)

Updated at December 05 11:30AM

Currency In CNY

Valuation

Market Cap33.44B
Enterprise Value32.57B
P/E Ratio1,653.77
PEG Ratio11.81
Price/Sales Ratio5.23
Price/Book Ratio3.83
Enterprise/Revenue5.04
Enterprise/EBITDA-315.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue5.19B
Revenue/Share0.38
Gross Profit653.37M
EBITDA-131.8M
Net Income8.57M
Diluted EPS0

Balance Sheet

Total Cash1.18B
Total Cash/Share0.09
Total Debt193.28M
Total Debt/Equity0.03
Current Ratio1.21
Book Value Per Share0.52

Price History

52-Week Change-17.77
52-Week High2.95
52-Week Low1.81
Moving Average 50 Days2.04
Moving Average 200 Days2.04

Statistics

Average Volume258.5M
Shares Outstanding13.83B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.05
Last Split Factor2:1
Last Split DateJune 16, 2015